Effectiveness and Safety of Tofacitinib as Adjunctive therapy for DRESS: A Real-World Study.
BACKGROUND Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe multisystem hypersensitivity reaction. While systemic glucocorticoids remain the cornerstone treatment, patients often exhibit resistance, intolerance, or relapse during tapering, highlighting an urgent need for effective strategies....